(Q82081130)

English

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13) when given as a toddler dose to children immunized with PCV7 as infants

scientific article published on 18 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008822%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13) when given as a toddler dose to children immunized with PCV7 as infants (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008822%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

pneumococcal conjugate vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

E Grimprel

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008822%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

F Laudat

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008822%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

S Patterson

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008822%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

S A Baker

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008822%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M S Sidhu

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008822%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

W C Gruber

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008822%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

E A Emini

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008822%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

D A Scott

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008822%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

18 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008822%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008822%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008822%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

52

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008822%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

9675-9683

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008822%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Serotype distribution and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from children in China younger than 5 years

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Emergence of Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes in the Era of 7-Valent Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Efficacy of pneumococcal conjugate vaccines in large scale field trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Monitoring the impact of vaccines postlicensure: new challenges, new opportunities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Pneumococcal necrotizing pneumonia in Utah: does serotype matter?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

An international serotype 3 clone causing pediatric noninvasive infections in Israel, Costa Rica, and Lithuania

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

A multi-laboratory evaluation of an enzyme-linked immunoassay quantitating human antibodies to Streptococcus pneumoniae polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Pneumococcal polysaccharide-protein CRM197 conjugate vaccines, 7- or 9-valent, in the 2 + 1 schedule

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.012

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.10.012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008822%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008822%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82081130&oldid=1780604951"